Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sunitinib in Advanced Cholangiocarcinoma
NCT01718327Phase 2Completed
- Sponsor
- GERCOR
- Start
- Sep 2011
- Primary completion
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sunitinib in intrahepatic cholangiocarcinoma (ICC), sponsored by GERCOR. Started Sep 2011; status: completed.
02
Drugs
sunitinib
03
Conditions
intrahepatic cholangiocarcinoma (ICC)
Beyond the preview
Go deeper on NCT01718327.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01718327.